Design Therapeutics
DSGN
DSGN
98 hedge funds and large institutions have $133M invested in Design Therapeutics in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 36 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+3
Holders Change %
+3.16%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
28
Reduced
36
Closed
10
Calls
$15K
Puts
$17K
Net Calls
-$2K
Net Calls Change
-$14K
Top Buyers
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.63M |
| 2 |
Walleye Capital
New York
|
-$871K |
| 3 |
D.E. Shaw & Co
New York
|
-$452K |
| 4 |
BlackRock
New York
|
-$385K |
| 5 |
Morgan Stanley
New York
|
-$379K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PP
101
PDT Partners
New York
| – | -$223K | -36,099 | Closed |
|
|
AG
102
Algert Global
San Francisco,
California
| – | -$100K | -16,238 | Closed |
|
|
BFG
103
Bleakley Financial Group
Fairfield,
New Jersey
| – | -$81.9K | -13,266 | Closed |
|
104
ProShare Advisors
Bethesda,
Maryland
| – | -$71.1K | -11,525 | Closed |
|
|
VWM
105
Venturi Wealth Management
Austin,
Texas
| – | -$4.65K | -753 | Closed |
|
|
AAP
106
Arax Advisory Partners
Denver,
Colorado
| – | -$883 | -143 | Closed |
|